Regulatory news
This entire item is of approximately 300 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the May 2011 issue of Biomedical Materials and download it online

  • Issue: May 2011, page: 9

    ReGen Biologics rejects US authority’s offer of further hearing

    The offer made by the US Food and Drug Administration (FDA) to ReGen Biologics Inc of a further hearing in the matter of approval of the company’s knee implant was rejected in March this year.

    Read related items on:

          
  • Medical
  • Legal and regulatory
  • ReGen Biologics
  • US Food and Drug Administration

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact